FASLG and neoplasm: Immunohistologically FAS-L expression was morphologically attributed to the tumor cells in liver metastases at late tumor stages (p < 0.05, day 10 compared to day 15, day 20 and normal tissue, respectively, Asterisk; Figure 4b, 5a).